BioXcel Therapeutics, Inc. Profile Avatar - Palmy Investing

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing …

Biotechnology
US, New Haven [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of BTAI's Analysis
CIK: 1720893 CUSIP: 09075P105 ISIN: US09075P1057 LEI: - UEI: -
Secondary Listings
BTAI has no secondary listings inside our databases.